CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows from Operating Activities:
Net income (loss)	$ 21,548,458	$ (1,495,018)
Adjustments to arrive at cash provided by operating activities:
Net premium and discount on investments	37,978	24,777
Depreciation and amortization	15,321	18,013
Stock options	11,934
Net transfers to noncontrolling interest	62,500
Amortization of deferred acquisition costs	40,509	2,069
Deferred acquisition costs capitalized	(1,483,941)	(253,186)
Net realized gains on investments	(22,600,010)	4,397
Deferred coinsurance ceding commission	1,033,940	(792,325)
Notes payable interest accrued		271,142
Preferred stock dividend		90,667
Changes in operating assets and liabilities:
Reinsurance recoverables	2,617,495	(204,111)
Interest and dividends due and accrued	(1,052,329)	(86,946)
Premiums receivable	5,599	(1,980)
Policy liabilities	1,699,134	276,747
Other assets and liabilities	379,158	2,042,291
Other assets and liabilities - discontinued operations	703	(145,981)
Net cash provided by or (used in) operating activities	2,316,449	(249,444)
Securities available for sale:
Purchases	(39,723,572)	(7,446,737)
Proceeds from sale or maturity	3,852,943	360,600
Mortgage loans on real estate, held for investment purchases
Purchases	(33,342,545)
Proceeds from sale	2,069,950
Purchase of derivatives	(651,661)
Other invested assets
Purchases	(2,715,965)
Proceeds from sale	2,388,560
Net change in policy loans	(22,720)	733
Net purchases of property and equipment	(8,998)	(3,818)
Net cash used in investing activities	(68,154,008)	(7,089,222)
Cash Flows from Financing Activities:
Finance lease	(111)	(111)
Receipts on deposit-type contracts	47,815,010	8,320,749
Withdrawals on deposit-type contracts	(186,689)
Net cash provided by financing activities	47,628,210	8,320,638
Net increase (decrease) in cash and cash equivalents	(18,209,349)	981,972
Cash and cash equivalents:
Beginning	43,716,205	2,832,567
Ending	$ 25,506,856	$ 3,814,539